🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 1st patient has been dosed in the Phase 1 clinical trial of MOMA-313, a novel, highly potent & selective oral POLq helicase inhibitor, & we've selected our 2nd development candidate, MOMA-341, an oral Werner helicase inhibitor. Read & learn more: businesswire.com/news/home/2024…

The House just passed a bill that makes the biggest cut to #Medicaid in history & kicks millions off health coverage. This will have a lasting impact on the fight against cancer. Health care costs will ⬆️& those who need screening/preventive care could have to go without. (1/2)

Great talk from Dr. M Overman MD Anderson Cancer Center re: overview on the role of #immunotherapy in #colorectalcancer. Looking forward to this paper in press from Van Morris, MD re: correlates from his phase 2 single arm study for BRAF refractory #CRCSM pts with IO. ESMO - Eur. Oncology #ESMOGI2025

Real-world data on the safety and eficacy of ENCO plus PANI in BRAF V600E mutated mCRC patients who experienced severe toxicity with CET. ORR, PFS and OS are comparable to those reported in the BEACON trial -> potential option in patients unable to continue CET. #ESMOGI2025

#ESMOGI25 ESMO - Eur. Oncology Proferred paper session #CRC 🚨 Can ctDNA guide surveillance & ⬆️ cure?➡️GALAXY/BESPOKE, FIND & ALTAIR 🩸🧬 Excellent discussion Jeanne Tie 👏 ⭐️ GALAXY/BESPOKE & FIND 📌v low risk if MRD- for > 18mos ⬆️ salvage tx but ?impact on QoL and OS. 🌟 ALTAIR

Happening now: Dr. Rene Adam providing an update on metastatic #colorectal #cancer to the liver regarding #Transmet study and #livertransplant. ESMO - Eur. Oncology #ESMOGI25 #ESMOGI2025 #Cancer #CancerResearch

Closing the session is #DrMichaelOverman re: where are with re: immunotherapy in met #crcsm #colorectal #cancer. Excellent lecture re: future developments! ESMO - Eur. Oncology #cancer #cancerresearch MD Anderson Cancer Center #ESMOGI2025 #ESMOAmbassadors

Closing remarks at ESMO - Eur. Oncology #ESMOGI25 Patient perspective lecture by #Dice Many steps to improve 👉Early diagnosis- let’s be proactive 👀Early on-set 🤝Decision making beyond signing informed consent 🫂Communication - what, how, when matters #ESMOAmbassadors

#ESMOGI25 was an incredible experience — truly honored to present results from the PARERE study by GONO Foundation in the Proffered Session

Phenomenal session by Dr Michael Overman of MD Anderson Cancer Center The OG showed up! Also his session for MSI crc was a tour de force! To see all that has happened and that a better future is on the brink. Worldwide efforts paying off!

Over the weekend at #ESMOGI25, our botensilimab/balstilimab investigational combo presented new MSS #colorectalcancer data, showing consistent results over extended follow-up. See the full presentation here: bit.ly/4lHjMxE #Immunotherapy #CancerResearch

#TumorBoardTuesday 😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer So to put this in context: 📢Join us Tuesday, 07-08-25 at 8PM ET as Dr. Shubham Pant & Daniel Haldar 🗣️Optimizing 1L Treatment Selection in mPDAC RT and bring others into the discussion‼️

📘Early-onset colorectal cancer ASCO Educational Book 👉ascopubs.org/doi/10.1200/ED… #cancer #oncology #MedX OncoAlert Dr Joseph McCollom DO

I was patient advocate voice on the Fight Colorectal Cancer webinar Research Updates from ASCO 2025 Six presentations discussed by Dr. Smitha Krishnamurthi two I/O trials for MSS Stage IV patients (XTX101, DSP-107) BREAKWATER CHECKMATE 8HW ATOMIC CHALLENGE #ASCO25 #CRCSM youtube.com/watch?v=f8FZQO…

Join me live tomorrow at 7pm ET on Zoom to hear from Dr. Kevin Burns, MD on #histotripsy for colorectal cancer liver mets—details on flyer. 💙 #crcsm #mCRC #livermets Histosonics Inc. COLONTOWN Manju George MVSc PhD Rectal Cancer Survivor A.n.n.

Implications of BRAF V600E in dMMR/MSI-H pts treated with ICIs. Prognostic impact of the BRAF V600E mutation in patients with MSI-high... sciencedirect.com/science/articl… AACR Journal of Clinical Oncology ASCO Mayo Clinic Comprehensive Cancer Center

💯 % agree “discontinuing trials for which participants have already volunteered and are undergoing treatment does an enormous disservice to patients.”

NCT06974110 open in TX & Australia #AACR25 preclinical research Direct measurement of TA repeat expansions significantly outperforms MSI-H status as a predictor of sensitivity to the novel WRN inhibitor MOMA-34 aacrjournals.org/.../85/8_Suppl… Poster on MT website momatx.com/wp-content/upl…

Really impressed by the Resources from the Cleveland Clinic Center for Young-Onset Colorectal Cancer - for patients and their family members David Liska Smitha Krishnamurthi my.clevelandclinic.org/departments/di… Phuong Gallagher Fight Colorectal Cancer Colon Camp!

Wow. I am updating my profile to 18 year survivor instead of 17 years. I am here to show that early age onset of colorectal cancer can be a long and incredible life. I stand proud as a research advocate to show that the patient voice is important and not to be disregarded.